Predictive Value of Interleukin-5 and Monocyte Chemotactic Protein-1 for Bacteremia in Children With Febrile Neutropenia

被引:11
作者
Aquino, Victor M. [1 ,2 ]
Cost, Carrye [1 ,2 ]
Gomez, Ana [3 ]
Bowers, Daniel C. [1 ,2 ]
Ramilo, Octavio [4 ]
Ahmad, Naveed [5 ,6 ]
Winick, Naomi [1 ,2 ]
Leavey, Patrick J. [1 ,2 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Pediat, Div Pediat Hematol, Dallas, TX 75290 USA
[2] Univ Texas SW Med Ctr Dallas, Dept Pediat, Div Oncol, Dallas, TX 75290 USA
[3] Univ Texas SW Med Ctr Dallas, Dept Infect Dis, Dallas, TX 75290 USA
[4] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75290 USA
[5] Childrens Med Ctr, Dallas, TX 75235 USA
[6] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA
关键词
fever; neutropenia; interleukin-5; oncology; pediatrics; C-REACTIVE PROTEIN; PEDIATRIC CANCER-PATIENTS; TUMOR-NECROSIS-FACTOR; LOW-RISK; SERUM-LEVELS; ONCOLOGY PATIENTS; PROCALCITONIN CONCENTRATIONS; OUTPATIENT MANAGEMENT; ORAL CIPROFLOXACIN; DIAGNOSTIC-VALUE;
D O I
10.1097/MPH.0b013e31824e498d
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A variety of clinical and laboratory parameters have been used to predict bacteremia. We hypothesize that the generation of a cytokine profile could be used to identify patients at higher risk of bacteremia at the time of presentation with febrile neutropenia. We prospectively evaluated children with cancer who presented with an episode of febrile neutropenia. A multiplexed flow cytometric assay was performed which measured 15 cytokines and chemokines obtained before the initiation of antibiotics. Fifty-eight episodes of chemotherapy-induced febrile neutropenia were included in this study during which 4 patients (7%) had bacteremia. An interleukin-5 level of >8 pg/dL had a sensitivity of 67% and a specificity of 96% to predict bacteremia. An monocyte chemotactic protein-1 level >1650 pg/dL had a sensitivity of 80% and a specificity of 82% to predict bacteremia. Erythrocyte sedimentation rate, C-reactive protein, protein C, and other cytokines/chemokines were not predictive of bacteremia. Elevations of interleukin-5 and monocyte chemotactic protein-1 are predictive of bacteremia in children with cancer who have febrile neutropenia. Prospective studies should be undertaken to determine whether these parameters retain predictive value in a larger series of patients and can select children for outpatient management or early discharge.
引用
收藏
页码:E241 / E245
页数:5
相关论文
共 46 条
[1]  
Aquino VM, 2000, CANCER, V88, P1710, DOI 10.1002/(SICI)1097-0142(20000401)88:7<1710::AID-CNCR27>3.3.CO
[2]  
2-T
[3]  
Arber C, 2000, SCAND J INFECT DIS, V32, P515, DOI 10.1080/003655400458802
[4]   INTERLEUKIN-8, A CHEMOTACTIC AND INFLAMMATORY CYTOKINE [J].
BAGGIOLINI, M ;
CLARKLEWIS, I .
FEBS LETTERS, 1992, 307 (01) :97-101
[5]  
Bartolo E, 2001, CANCER, V92, P909
[6]   INTERLEUKIN-6 AND ITS RECEPTOR DURING HOMEOSTASIS, INFLAMMATION, AND TUMOR-GROWTH [J].
BAUER, J .
KLINISCHE WOCHENSCHRIFT, 1989, 67 (14) :697-706
[7]   Plasma IL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia [J].
de Bont, ESJM ;
Vellenga, E ;
Swaanenburg, JCJM ;
Fidler, V ;
Visser-van Brummen, PJ ;
Kamps, WA .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 107 (02) :375-380
[8]   Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells [J].
de Jager, W ;
te Velthuis, H ;
Prakken, BJ ;
Kuis, W ;
Rijkers, GT .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2003, 10 (01) :133-139
[9]   Monocyte Chemoattractant Protein-1 (MCP-1): An Overview [J].
Deshmane, Satish L. ;
Kremlev, Sergey ;
Amini, Shohreh ;
Sawaya, Bassel E. .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2009, 29 (06) :313-326
[10]   Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: Comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia [J].
deWerra, I ;
Jaccard, C ;
Corradin, SB ;
Chiolero, R ;
Yersin, B ;
Gallati, H ;
Assicot, M ;
Bohuon, C ;
Baumgartner, JD ;
Glauser, MP ;
Heumann, D .
CRITICAL CARE MEDICINE, 1997, 25 (04) :607-613